Evolent Health, Inc. (EVH)

Evolent Health, Inc. (EVH) is a healthcare company (health information services) based in the United States. The share price is $4.63, down 4.14% on the day, which values the company at $523.68M. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$4.63−4.14% today
Market value
$523.68M
Forward P/E
10.9×
Funk Score
39/100
Against its own history
Well below its usual priceusual price $17.12
200-week average
$17.0773% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Evolent Health, Inc. in more detail

EVH trades at 10.9× next year's expected earnings, 0.2× sales. Measured against its own history, the price is 73% below what its usual multiples would imply ($17.12) — well below its usual price. It sits 73% below its 200-week average of $17.07.

Over the last five fiscal years Evolent Health, Inc. has compounded revenue 15.2% a year. Its Funk Score is 39 out of 100 (financial strength 1.7, profitability 1.6, growth 6.7, value 5.3, each out of 10).

Worth checking: Altman Z in the distress zone; Thin interest cover.

2 of the superinvestors tracked here hold EVH, including Glenn Welling (9.2% of the portfolio), Eric Bannasch (0.1% of the portfolio).

Superinvestors holding EVH

2 of the investors tracked here report a position in their latest 13F filing.

Evolent Health, Inc. (EVH): questions and answers

What is EVH's PEG ratio?

Evolent Health, Inc.'s PEG ratio is 1.93 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Evolent Health, Inc.'s market cap?

Evolent Health, Inc. is valued at $523.68M at a share price of $4.63.

Is EVH overvalued or undervalued?

Against its own history, EVH is well below its usual price: the price is 73% below the $17.12 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is EVH above its 200-week moving average?

No. EVH is 72.9% below its 200-week average of $17.07. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Evolent Health, Inc. growing?

Over the last five fiscal years Evolent Health, Inc.'s revenue grew 15.2% a year.

Does EVH pay a dividend?

Evolent Health, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Evolent Health, Inc. (EVH) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/EVH

Underlying data: Yahoo Finance; company filings with the SEC.